Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RAtrium Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

Atrium Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Sep 18, 2026Gallagher Kathleen P.See Remarks11,632Common Stock—Tax withholding
Sep 18, 2026Boyce SarahDirector126,418Common Stock—Tax withholding
Sep 18, 2026Flanagan W. MichaelDirector22,812Common Stock—Tax withholding
Sep 18, 2026Hughes Steven GeorgeChief Medical Officer21,459Common Stock—Tax withholding
Sep 18, 2026Hoyos Rocio MartinChief Strategy Officer8,320Common Stock—Tax withholding
Sep 18, 2026Winslow Brendan R.Chief Financial Officer6,742Common Stock—Tax withholding
Sep 18, 2026Kenney StephanieSee Remarks2,375Common Stock—Tax withholding
Sep 18, 2026Younis HusamChief Scientific Officer11,216Common Stock—Tax withholding
Apr 20, 2026Younis HusamChief Scientific Officer60,000Stock Option (Right to Buy)—Grant / award
Apr 20, 2026Younis HusamChief Scientific Officer30,000Common Stock—Grant / award
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions